VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, will participate in the Association for ...

Utah-based Vector Defense is pioneering a service-based model for delivering and upgrading military drones, bypassing lengthy ...

Vector Science & Therapeutics (the "Company") today announced the filing of a provisional patent application covering a novel catheter-based platform designed for intratumoral drug delivery research, ...

High-throughput virology, design of experiments, and small-molecule production enhancers optimize yield and increase ...

Enrolment completed in Phase 2 part of head and neck cancer clinical trial (TG4050) – Topline data expected by the end of Q1 2028 as per plan ...

Canadian cybersecurity startup stops multi-vector attack during live training event with zero service disruption We had ...

First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent® global net sales(recorded by Sanofi) increased 33% ...

Developed by American Biotechnology company Regeneron, Otarmeni has been approved for the treatment of pediatric and adult patients with severe-to-profound and profound sensorineural hearing loss. The ...

New solutions include customized reagents that scale from bench to clinical trials, industrialized lentiviral vector ...

Advanced non-viral gene delivery systems are expanding the range of indications and therapy modalities possible for the new generation of genetic medicines.

The biggest barrier between philanthropic resources and communities isn't billionaires - it's the credentialed professionals ...

The COVID-19 pandemic substantially affected routine childhood immunization delivery, vaccine confidence, and equitable access to preventive care. In the ...